Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer

被引:58
作者
Ding, Xiao [1 ,2 ]
Ji, Wei [1 ,2 ,4 ]
Li, Junling [2 ,3 ]
Zhang, Xiangru [2 ,3 ]
Wang, Luhua [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Radiat Oncol, Canc Inst Hosp, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100037, Peoples R China
[4] Fudan Univ, Dept Radiat Oncol, Zhong Shan Hosp, Shanghai 200433, Peoples R China
关键词
GEMCITABINE; DERMATITIS; SUPRAGLOTTITIS; PACLITAXEL; TAMOXIFEN; THERAPY; PATIENT;
D O I
10.1186/1748-717X-6-24
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiation recall pneumonitis (RRP) describes a rare reaction in previously irradiated area of pulmonary tissue after application of triggering agents. RRP remains loosely characterized and poorly understood since it has so far only been depicted in 8 cases in the literature. The objective of the study is to disclose the general characteristics of RRP induced by chemotherapy after thoracic irradiation for lung cancer, and to draw attention to the potential toxicity even after a long time interval from the previous irradiation. Methods: Medical records were reviewed. RRP induced by chemotherapy was diagnosed by the history of chemotherapy after radiotherapy, clinical presentation and radiographic abnormalities including ground-glass opacity, attenuation, or consolidation changes within the radiation field, plus that radiographic examination of the thorax before showed no radiation pneumonitis. RRP was graded according to Common Terminology Criteria for Adverse Events version 3.0. The characteristics of the 12 RRP cases were analyzed. Results: Twelve patients were diagnosed of RRP, of who 8 received taxanes. The median time interval between end of radiotherapy and RRP, between end of radiotherapy and beginning of chemotherapy, and between beginning of chemotherapy and RRP was 95 days, 42 days and 47 days, respectively. Marked symptomatic and radiographic improvement was observed in the 12 patients after withdrawal of chemotherapy and application of systemic corticosteroids. Seven patients were rechallenged with chemotherapy, of whom four with the same kind of agents, and showed no recurrence with steroid cover. Conclusions: Doctors should pay attention to RRP even after a long time from the previous radiotherapy or after several cycles of consolidation chemotherapy. Taxanes are likely to be associated with radiation recall more frequently. Withdrawal of causative agent and application of steroids are the treatment of choice. Patients may be rechallenged safely with steroid cover and careful observation, which needs to be validated.
引用
收藏
页数:6
相关论文
共 31 条
[1]  
Abadir R, 1995, Clin Oncol (R Coll Radiol), V7, P325, DOI 10.1016/S0936-6555(05)80545-X
[2]   Radiation recall:: A well recognized but neglected phenomenon [J].
Azria, D ;
Magné, N ;
Zouhair, A ;
Castadot, P ;
Culine, S ;
Ychou, M ;
Stupp, R ;
Van Houtte, P ;
Dubois, JB ;
Ozsahin, M .
CANCER TREATMENT REVIEWS, 2005, 31 (07) :555-570
[3]   Radiation recall -: Another call with tamoxifen [J].
Boström, Å ;
Sjölin-Forsberg, G ;
Wilking, N ;
Bergh, J .
ACTA ONCOLOGICA, 1999, 38 (07) :955-959
[4]   ADRIAMYCIN-INDUCED RECALL PHENOMENON 15 YEARS AFTER RADIOTHERAPY [J].
BURDON, J ;
BELL, R ;
SULLIVAN, J ;
HENDERSON, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (10) :931-931
[5]  
Camidge R, 2002, J CLIN ONCOL, V20, P4130, DOI 10.1200/JCO.2002.99.148
[6]   Characterizing the phenomenon of radiation recall dermatitis [J].
Camidge, R ;
Price, A .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (03) :237-245
[7]   Biweekly vinorelbine and gemcitabine:: a phase I dose-finding study in patients with advanced solid tumors [J].
Castellano, D ;
Hitt, R ;
Ciruelos, E ;
Cortés-Funes, H ;
Colomer, R .
ANNALS OF ONCOLOGY, 2003, 14 (05) :783-787
[8]  
Chan RTT, 2001, CLIN ONCOL-UK, V13, P55, DOI 10.1007/s001740170115
[9]   Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis [J].
Choi, YW ;
Munden, RF ;
Erasmus, JJ ;
Park, KJ ;
Chung, WK ;
Chol Jeon, S ;
Park, CK .
RADIOGRAPHICS, 2004, 24 (04) :985-997
[10]  
EXTERMANN M, 1995, EUR J CLIN PHARMACOL, V48, P77